Roivant Sciences Ltd. – Investors and Politicians Who Own It
ROIV, 2 share classes and securities
Investors who own it
10 tracked investors, $1.8B in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Farallon Capital ManagementQ2 2026 | $506.4M | 2.34% |
Joseph EdelmanPerceptive Advisors, Q2 2026 | $286.1M | 4.30% |
Darwin Global ManagementQ2 2026 | $234.3M | 6.23% |
Andreas HalvorsenViking Global Investors, Q2 2026 | $221.9M | 0.63% |
David RosenRubric Capital Management, Q2 2026 | $212.3M | 1.95% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $166.9M | 0.84% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $111.7M | 5.11% |
Lee AinslieMaverick Capital, Q2 2026 | $100.1M | 0.88% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $5.2M | 0.01% |
Polen CapitalQ2 2026 | $306.4K | 0.00% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Andreas Halvorsen | Reduced −26% | 34,237,779 |
| David Rosen | Added +15% | 20,370,336 |
| Joseph Edelman | New | 3,331,465 |
| Daniel Schneeberger | Reduced −44% | 1,940,797 |
| Anand Parekh | New | 115,866 |
| Zach Schreiber | Reduced −11% | 2,426,563 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
| Politician | Action | Traded |
|---|---|---|
Lisa C. McClainSpouseR-MI · House | Sold$1K–$15K | Oct 31, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Sold$1K–$15K | Oct 30, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Bought$1K–$15K | Oct 30, 2025disclosed Nov 21, 2025 |
Lisa C. McClainSpouseR-MI · House | Bought$1K–$15K | Jun 17, 2025disclosed Aug 13, 2025 |